Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
08/10/2000 | WO2000046585A2 Method for enriching or depleting tumour cells obtained from a body fluid and kit suitable for this purpose |
08/10/2000 | WO2000046407A2 Methods of utilizing the tt virus |
08/10/2000 | WO2000046404A1 Method of diagnosing of exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes |
08/10/2000 | WO2000046402A1 Genomic analysis method |
08/10/2000 | WO2000046399A1 Method for predicting fiber length using qtl's and molecular markers |
08/10/2000 | WO2000046398A1 Use of fluorescent molecular beacons in the detection of methylated nucleic acids |
08/10/2000 | WO2000046396A1 New assay |
08/10/2000 | WO2000046394A2 Tryptophan synthase as a site of herbicide action |
08/10/2000 | WO2000046391A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
08/10/2000 | WO2000046374A1 $i(candida albicans) srb-7 |
08/10/2000 | WO2000046367A2 Proteins capable of triggering g2/m transition and of interacting with cdc2- and cyclin b |
08/10/2000 | WO2000046357A1 Assay with reduced background |
08/10/2000 | WO2000046352A1 Human t cell effectors expressing cd86 molecule and therapeutic use thereof |
08/10/2000 | WO2000046348A1 Method for inducing differentiation into adipocytes, compound regulating differentiation into adipocytes and method for screening the same |
08/10/2000 | WO2000046344A2 Non-stochastic generation of genetic vaccines and enzymes |
08/10/2000 | WO2000046343A2 Screening assay for antagonists of fgfr-mediated malignant cell transformation and tumor formation |
08/10/2000 | WO2000046246A1 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease |
08/10/2000 | WO2000046244A1 cDNA SEQUENCE OF AN INTERACTOR FANCIP1 OF THE FANCONI ANAEMIA PROTEIN OF COMPLEMENTATION GROUP A |
08/10/2000 | WO2000046236A2 Novel rgs-containing molecules and uses thereof |
08/10/2000 | WO2000045953A1 Device for selectively regulating the temperature of individual containers |
08/10/2000 | WO2000045852A1 Method of treating cancer by restoration of pp32 function |
08/10/2000 | WO2000045851A2 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin |
08/10/2000 | WO2000045840A1 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence |
08/10/2000 | WO2000045838A1 A METHOD FOR TARGETED DEGRADATION OF INTRACELLULAR PROTEINS IN VIVO OR $i(EX VIVO) |
08/10/2000 | WO2000045832A2 Regulation of anaesthesia |
08/10/2000 | WO2000045705A1 Device for receiving and controlling voided urine |
08/10/2000 | WO2000045702A1 Automatic lung parameter estimator |
08/10/2000 | WO2000045697A1 Method and apparatus for detecting a magnetically responsive substance |
08/10/2000 | WO2000045696A1 Holter-type monitor system comprising an analyte sensor |
08/10/2000 | WO2000045633A1 Transgenic animal showing vascular tissue-specific expression of angiotensin ii2 receptor |
08/10/2000 | WO2000033080A3 New assay |
08/10/2000 | WO2000033073A3 Method for detecting no in the whole blood of mammals |
08/10/2000 | WO2000030750A3 Method for operating a water softening ion exchanger system with regenerative unit by measuring in situ the water hardness by means of an ion-selective sensory mechanism and arrangement for carrying out such a method |
08/10/2000 | WO2000029008A3 Hiv-specific t-cell induction |
08/10/2000 | WO2000026251A3 A COMPLEX OF A CHAPERONE WITH ss-AMYLOID AND METHODS EMPLOYING THIS COMPLEX |
08/10/2000 | WO2000026239A3 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
08/10/2000 | WO2000025106A3 Pharmacophore fingerprinting in qsar and primary library design |
08/10/2000 | WO2000024937A3 Parallel methods for genomic analysis |
08/10/2000 | WO2000024773A3 Inhibition of transglutaminase-mediated microbial infection of a mammalian host |
08/10/2000 | WO2000023583A3 p53 BINDING AREAS |
08/10/2000 | WO2000016099A9 Recombinant reduced valency carbohydrate binding ligands |
08/10/2000 | WO2000013706A8 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor |
08/10/2000 | WO2000012754A8 Method for identifying substances for the treatment of c-jun-mediated disorders |
08/10/2000 | WO2000010588A9 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
08/10/2000 | WO2000010584A9 Method for detection of legionella bacteria employing purified antigen-specific antibodies |
08/10/2000 | WO2000003699A3 Drugs containing phosphoric acid derivatives as active ingredient and their use |
08/10/2000 | WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors |
08/10/2000 | DE19956466A1 Monitoring apparatus for detecting dioxine content of exhaust gas from refuse incinerator, motor vehicle, carries out mass spectrometry of ions from ion source which ionizes minor constituents in sample gas |
08/10/2000 | DE19938839A1 Verfahren zum Nachweis von Analyten in einer Meßprobe sowie Meßträger hierfür A method for the detection of analytes in a sample to be measured and measuring support therefor |
08/10/2000 | DE19906169A1 Testkit und Verfahren zum quantitativen Nachweis von gentechnisch veränderter DNS in Lebensmitteln mittels fluoreszenzgekoppelter PCR Test kit and method for the quantitative detection of genetically modified DNA in food by fluorescence-coupled PCR |
08/10/2000 | DE19904267A1 Verfahren zur Anreicherung von Tumorzellen aus einer Körperflüssigkeit und dazu geeigneter Kit A process for the enrichment of tumor cells from a body fluid and to a suitable kit |
08/10/2000 | DE19903506A1 Verfahren, Gefäß und Vorrichtung zur Überwachung der Stoffwechselaktivität von Zellkulturen in flüssigen Medien A method, vessel and apparatus for monitoring the metabolic activity of cell cultures in liquid media |
08/10/2000 | DE10004910A1 Carbon and silicon content thermal analysis, for molten cast iron or pig iron, comprises comparing crystallization start temperatures of melts in sample vessels containing small amounts of tellurium and silicon respectively |
08/10/2000 | DE10004335A1 Machine for fatigue testing samples of foamed polyurethane etc has one set of horizontal plates for supporting samples and another vertically movable set of plates for compressing samples |
08/10/2000 | CA2384337A1 Method of detecting analytes in a sample and support for this purpose |
08/10/2000 | CA2362239A1 Novel rgs-containing molecules and uses thereof |
08/10/2000 | CA2361923A1 Multichannel control in microfluidics |
08/10/2000 | CA2361838A1 Method of treating cancer by restoration of pp32 function |
08/10/2000 | CA2361703A1 Tryptophan synthase as a site of herbicide action |
08/10/2000 | CA2361654A1 Use of fluorescent molecular beacons in the detection of methylated nucleic acids |
08/10/2000 | CA2361599A1 Methods of utilizing the tt virus |
08/10/2000 | CA2360942A1 Preparations for preventing and/or treating a tissue change of mesenchymal origin |
08/10/2000 | CA2360932A1 A surface plasmon resonance sensor |
08/10/2000 | CA2360929A1 Genomic analysis method |
08/10/2000 | CA2360834A1 Candida albicans srb-7 |
08/10/2000 | CA2360745A1 Screening assay for antagonists of fgfr-mediated malignant cell transformation and tumor formation |
08/10/2000 | CA2360741A1 Protein with cell proliferation and cell division modulating activity and dna encoding such protein |
08/10/2000 | CA2360688A1 Human t cell effectors expressing cd86 molecule and therapeutic use thereof |
08/10/2000 | CA2360684A1 Method for inducing differentiation into adipocytes, compounds controlling such differentiation and method of screening for same |
08/10/2000 | CA2360124A1 Regulation of anaesthesia |
08/10/2000 | CA2359469A1 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence |
08/10/2000 | CA2358680A1 New assay |
08/10/2000 | CA2358589A1 Method for predicting fiber length using qtl's and molecular markers |
08/09/2000 | EP1026516A2 Method and apparatus for analyzing an ultrasonic image of a carcass |
08/09/2000 | EP1026506A1 Ready-for-use calibrators for assaying procalcitonin |
08/09/2000 | EP1026505A1 A complex buffer system for the CZE analysis of hirudin |
08/09/2000 | EP1026504A1 Method for assaying receptor binding property and reagent for the assay |
08/09/2000 | EP1026503A2 Liquid specimen collection device |
08/09/2000 | EP1026263A2 Oligonucleotide reverse transcription primers for efficient detection of HIV-1 and HIV-2 and methods of use thereof |
08/09/2000 | EP1026260A1 Simultaneous measurement of gene expression and genomic abnormalities using nucleic acid microarrays |
08/09/2000 | EP1026251A2 Transgenic animals expressing human P25 |
08/09/2000 | EP1026246A1 Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same |
08/09/2000 | EP1026245A1 Antigen protein and nucleic acid coding for said protein |
08/09/2000 | EP1026244A1 Proteins Capable of Triggering G2/M transition and of Interacting with CDC2- and Cyclin B |
08/09/2000 | EP1026238A2 Cloned glutamic acid decarboxylase |
08/09/2000 | EP1026237A2 Tau/neurofilament protein kinases pk40 & pk36 |
08/09/2000 | EP1026173A1 Antihuman thymidylate synthase monoclonal antibodies and hybridomas producing the same |
08/09/2000 | EP1026156A2 Novel 10, 10'-substituted-9,9'-biacridine luminescent molecules and their preparation |
08/09/2000 | EP1025872A2 Tube set for a cell separator for separating blood into its components and cell separator using the tube set |
08/09/2000 | EP1025849A1 Methods for detection and treatment of individuals having abnormal cells expressing HLA-A2/tyrosinase peptide antigens |
08/09/2000 | EP1025758A1 Enhancing antimicrobial activity |
08/09/2000 | EP1025445A2 Measurement of glycated hemoglobin |
08/09/2000 | EP1025444A1 Determination of cellular growth abnormality |
08/09/2000 | EP1025443A1 Method for evaluating an effect characteristic of a biochemically active stimulation means |
08/09/2000 | EP1025442A1 Analytical device with capillary reagent carrier |
08/09/2000 | EP1025441A1 Pharmaceutical grade echinacea |
08/09/2000 | EP1025440A1 Mastitis assay |
08/09/2000 | EP1025439A1 Membrane based electrochemical test device and related methods |
08/09/2000 | EP1025438A2 Combustibility monitor and monitoring method |
08/09/2000 | EP1025437A1 A method for determining the affinity of proteins for chemical agents during screening of combinatorial libraries |